Applied DNA Sciences price target lowered to $1.50 from $2 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Applied DNA Sciences to $1.50 from $2 and keeps a Buy rating on the shares. The company’s revenue exhibited sequential growth in fiscal Q1, the analyst tells investors in a research note. The firm believes Applied’s revenue may increase significantly in the second half of 2024, driven by customer orders for critical starting materials for mRNA therapeutics.